Hem › Icke-småcellig lungcancer › New York › Albany
Kliniska studier för Icke-småcellig lungcancer i Albany, NY
9 studier för Icke-småcellig lungcancer söker deltagare vid platser i och runt Albany (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
RekryterarFas 3
- New York Oncology Hematology, P.C. ( Site 0132), Albany
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
RekryterarFas 3
- New York Oncology Hematology, P.C. ( Site 0119), Albany
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
RekryterarFas 3
- New York Oncology Hematology, P.C. ( Site 9000), Albany
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
RekryterarFas 3
- New York Oncology Hematology P.C ( Site 9000), Albany
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekryterarFas 3
- New York Oncology Hematology, Albany
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekryterarFas 2/3
- New York Oncology Hematology - Albany Medical Center, Albany
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
RekryterarFas 2
- ONE Onc: New York Oncology Hematology, Albany
MYLUNG Consortium Part 3: Observational Study
RekryterarObservationsstudie
- New York Oncology Hematology, P.C., Albany
GEMINI-NSCLC: NSCLC Biomarker Study
RekryterarObservationsstudie
- New York Oncology Hematology, Albany
Icke-småcellig lungcancer-studier i andra städer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andra studier i Albany
- Hjärt-kärlsjukdom7 studier
- Hjärtsvikt6 studier
- Övervikt6 studier
- Cancer (alla typer)5 studier
- Stroke4 studier
- Högt blodtryck4 studier
- Burkitts lymfom4 studier
- Multipelt myelom4 studier
- Alzheimers sjukdom4 studier
- Magsjukdomar4 studier
- Blåscancer4 studier
- Bröstcancer4 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.